Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06262321 · ClinicalTrials.gov registry record · Phase 2
Thoracic Radiotherapy for Patients With Metastatic (Stage IV) Non-Small Cell Lung Cancer at High Risk of Symptomatic Progression Within the Thorax
A Phase 2 study of Radiotherapy and Stage 4 NSCLC, sponsored by University of Rochester.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT06262321: Recruiting Phase 2 study of Radiotherapy and Stage 4 NSCLC, sponsored by University of Rochester.
NCT06262321 is a Phase 2 study of Radiotherapy and Stage 4 NSCLC that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 48 participants, below the 91-participant average among 4 other Radiotherapy trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06262321, a Phase 2 study of Radiotherapy and Stage 4 NSCLC, is actively recruiting participants, sponsored by University of Rochester.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients with metastatic non small cell lung cancer with high risk location or size are treated with prophylactic radiation therapy in conjunction with standard of care systemic therapy.
Primary Outcome
Kaplan-Meier freedom from symptomatic progression of irradiated thoracic target(s) at 6 months, 1 year, and 2 years.
Conditions Studied
Interventions
- RADIATION Prophylactic Palliative Radiotherapy
Study Locations (1)
New York
- University of Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2024-05-15 |
| Est. Completion | 2029-02-01 |
| Phase | Phase 2 |
What NCT06262321 shows while recruiting
NCT06262321 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 91-participant average among 4 other Radiotherapy trials with a reported enrollment target (47% lower).
The record links to 2 conditions, with Radiotherapy appearing as the primary indexed condition, and to 1 intervention - of which Prophylactic Palliative Radiotherapy is the first listed.
NCT06262321 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06262321 about?
NCT06262321 is a clinical study titled "Thoracic Radiotherapy for Patients With Metastatic (Stage IV) Non-Small Cell Lung Cancer at High Risk of Symptomatic Progression Within the Thorax". Patients with metastatic non small cell lung cancer with high risk location or size are treated with prophylactic radiation therapy in conjunction with standard of care systemic therapy.
What is the current status of trial NCT06262321?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 48 participants. The study started on 2024-05-15. Estimated completion is 2029-02-01.
What conditions does trial NCT06262321 study?
This clinical trial studies the following conditions: Radiotherapy, Stage 4 NSCLC.
What interventions are being tested in trial NCT06262321?
The interventions under investigation include: Prophylactic Palliative Radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT06262321?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06262321 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Radiotherapy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI